Phothera said Aetna updated its coverage policy to include home NB-UVB phototherapy for vitiligo, effective July 2026. The change expands payer coverage for the treatment by enabling at-home administration rather than limiting therapy setting. Overall, this is a modest positive commercial update that could support demand for Phothera’s products/services.
Phothera said Aetna updated its coverage policy to include home NB-UVB phototherapy for vitiligo, effective July 2026. The change expands payer coverage for the treatment by enabling at-home administration rather than limiting therapy setting. Overall, this is a modest positive commercial update that could support demand for Phothera’s products/services.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.20
